Lion Point Capital, LP: 13F holdings
CIK 16433542026Q2
| Positions | 35 |
|---|---|
| Reported value | $20.9m |
| Filed | 2026-08-14 |
Top 10 holdings
| Security | Shares | Value | Weight |
|---|---|---|---|
| CUE BIOPHARMA INC | 52,928 | $1.7m | 8.0% |
| PRAX PRAXIS PRECISION MEDICINES I | 4,450 | $1.5m | 7.1% |
| MOONLAKE IMMUNOTHERAPEUTICS | 67,500 | $1.3m | 6.3% |
| FENNEC PHARMACEUTICALS INC | 112,434 | $1.2m | 5.8% |
| ROYALTY PHARMA PLC | 21,400 | $1.2m | 5.7% |
| COMPASS PATHWAYS PLC | 80,000 | $1.1m | 5.4% |
| MILESTONE PHARMACEUTICALS IN | 820,000 | $1.1m | 5.3% |
| BENITEC BIOPHARMA INC | 62,000 | $829,560 | 4.0% |
| SNDX SYNDAX PHARMACEUTICALS INC | 36,000 | $786,960 | 3.8% |
| BIOHAVEN LTD | 51,700 | $769,296 | 3.7% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1643354")Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.